Search

everythinglearnresearchcommunity

for

Search:↓

Etoposide is effective in treating several cancers, especially small cell lung cancer, with acceptable side effects.

Low dose valproic acid treatment caused hair loss in a young patient.

The research predicted the effectiveness of Ayurvedic hair care products by calculating their Drug Efficacy Indices.

Protoporphyrin IX is useful in cancer treatment but can cause health problems if not properly regulated.

Valproic Acid helps regrow hair in mice and activates a hair growth marker in human cells.

Children taking higher doses of valproic acid had lower biotinidase activity, which may lead to biotin deficiency, but biotin supplements could help.

Tiny needles with valproic acid can effectively regrow hair.

Valproic acid may help hair grow and could be a safe treatment for hair loss.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Blocking a protein called CXXC5 with a specific peptide can stimulate hair regrowth and new hair growth in wounds.

Valproic acid increases hair count in men with hair loss.

Valproic acid treatment may cause temporary hair loss due to reduced zinc and biotinidase levels, which tend to normalize after 6 months.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

Biotin supplements increased biotin levels but did not significantly prevent hair loss in rats on valproic acid.

Valproic acid treatment increases a specific acid in urine by blocking an enzyme, possibly causing skin rash and hair loss.

Valproic acid can cause hair loss, but information on hair color change is not detailed.

HIV-1 may cause increased stem cell death in hair follicles, leading to hair loss.

Valproic acid may cause hair loss by reducing biotinidase enzyme activity in rats.

Valproic acid increases the risk of hair loss more than other drugs, especially in migraine patients, and lamotrigine may be a safer alternative.

Valproic acid can cause reversible hair curling and persistent hair thinning.

Levetiracetam often causes behavioral issues, while oxcarbazepine is more likely to cause sleepiness in epilepsy patients.

Male mice are more susceptible to autism-like changes from valproic acid than female mice.

Valproate can cause brain swelling with high ammonia levels, possibly underreported, especially in psychiatric patients.

Valproate sustained-release is effective and generally safe for short-term treatment of new partial epilepsy.

Topical Valproate is safe for human skin and unlikely to cause irritation.

Valproic acid helped hair growth in alopecia patient; more research needed.

Platelet-rich plasma doesn't prevent hair loss from chemotherapy, and mononuclear cells only help against hair loss from one specific chemotherapy drug.

Mononuclear cells may protect against certain chemotherapy-induced hair loss.

Genetic variants can affect valproic acid's effectiveness, side effects, and levels in epilepsy treatment.